
In collaboration with Julius Clinical, TRICALS will present the webinar: “Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors”. The webinar will take place on November 10, 2020 at 18:00 CET.
We are pleased to announce that this webinar will be presented by: Prof. Dr. Leonard van den Berg (Professor of Neurology and Chair of TRICALS) and Dr. Ruben van Eijk (Assistant Professor and Medical Statistician) from our TRICALS Centre at UMC Utrecht, the Netherlands.
Topics that will be covered, include:
- Prediction-based inclusion criteria
- Defining the concept of fast vs slow progressors
- Addressing disease heterogeneity and reduce variance
- Regulatory perspective (EMA) on prediction-based patient selection
Don’t miss this opportunity and register now by clicking the link: https://bit.ly/3oAnz2L. The webinar will be recorded, so even if you can’t make it, make sure to sign up to receive the replay!
Related news

Apellis reports discontinuation of MERIDIAN study
Pharmaceutical company Apellis has announced the discontinuation of the open-label phase of […]

Recording of virtual meeting - Adherence and retention in ALS clinical trials
On March 22, 2023, TRICALS organised its first virtual meeting: ‘Adherence and retention […]

COURAGE-ALS trial discontinued due to disappointing results
The company Cytokinetics has announced early termination of the COURAGE-ALS study. An […]

TRICALS consensus statement on Tofersen
OPINION: The consensus view of TRICALS neurologists is that Tofersen shows clear […]